Find Rimegepant Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Nurtec odt, Rimegepant sulfate [usan], 1374024-48-2, 1383nm3q0h, Rimegepant sulfate (usan), 1-piperidinecarboxylic acid, 4-(2,3-dihydro-2-oxo-1h-imidazo(4,5-b)pyridin-1-yl)-, (5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl ester, sulfate, hydrate (2:1:3)
Molecular Formula
C56H64F4N12O13S
Molecular Weight
1221.2  g/mol
InChI Key
SOGUOEZRYKUOHR-CQZKMDJHSA-N
FDA UNII
1383NM3Q0H

Rimegepant Sulfate
1 2D Structure

Rimegepant Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate;sulfuric acid;trihydrate
2.1.2 InChI
InChI=1S/2C28H28F2N6O3.H2O4S.3H2O/c2*29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37;1-5(2,3)4;;;/h2*1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37);(H2,1,2,3,4);3*1H2/t2*18-,22+,24-;;;;/m00..../s1
2.1.3 InChI Key
SOGUOEZRYKUOHR-CQZKMDJHSA-N
2.1.4 Canonical SMILES
C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.O.O.O.OS(=O)(=O)O
2.1.5 Isomeric SMILES
C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6.O.O.O.OS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
1383NM3Q0H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate

2. Bms-927711

3. Nurtec Odt

4. Rimegepant

2.3.2 Depositor-Supplied Synonyms

1. Nurtec Odt

2. Rimegepant Sulfate [usan]

3. 1374024-48-2

4. 1383nm3q0h

5. Rimegepant Sulfate (usan)

6. 1-piperidinecarboxylic Acid, 4-(2,3-dihydro-2-oxo-1h-imidazo(4,5-b)pyridin-1-yl)-, (5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl Ester, Sulfate, Hydrate (2:1:3)

7. Di((5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate), Monosulfate, Trihydrate

8. Unii-1383nm3q0h

9. Nurtec Odt (tn)

10. Rimegepant Sulfate Dihydrate

11. Chembl2364629

12. Dtxsid60160174

13. Rimegepant Sulfate [who-dd]

14. Rimegepant Sulfate [orange Book]

15. Rimegepant Hemisulfate Sesquihydrate

16. D10663

17. Rimegepant Hemisulfate Sesquihydrate [mi]

18. Q27251488

2.4 Create Date
2013-07-08
3 Chemical and Physical Properties
Molecular Weight 1221.2 g/mol
Molecular Formula C56H64F4N12O13S
Hydrogen Bond Donor Count9
Hydrogen Bond Acceptor Count23
Rotatable Bond Count8
Exact Mass1220.43726396 g/mol
Monoisotopic Mass1220.43726396 g/mol
Topological Polar Surface Area313 Ų
Heavy Atom Count86
Formal Charge0
Complexity973
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count6
4 Pharmacology and Biochemistry
4.1 FDA Pharmacological Classification
4.1.1 Pharmacological Classes
Calcitonin Gene-related Peptide Receptor Antagonists [MoA]; Calcitonin Gene-related Peptide Receptor Antagonist [EPC]

API SUPPLIERS

read-more
read-more

01

Moehs Iberica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Moehs Iberica

02

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

03

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Dr Reddy Company Banner

04

Jinan Tantu Chemicals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jinan Tantu Chemicals

05

Tagoor Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Tagoor Laboratories

06

Porton Pharma Solutions

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Porton Company Banner

07

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

08

Aurisco Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmex
Not Confirmed
arrow

Aurisco Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmex
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmex
Not Confirmed
arrow

Teva Pharmaceutical Industries

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmex
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharmex
Not Confirmed
arrow

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharmex
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-14

Pay. Date : 2023-09-26

DMF Number : 37797

Submission : 2022-12-23

Status : Active

Type : II

Moehs Iberica

02

IFT FIRST
Not Confirmed

03

IFT FIRST
Not Confirmed

03

IFT FIRST
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-13

Pay. Date : 2023-09-15

DMF Number : 38810

Submission : 2023-09-28

Status : Active

Type : II

blank

04

IFT FIRST
Not Confirmed

04

IFT FIRST
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-09-25

Pay. Date : 2023-08-24

DMF Number : 38655

Submission : 2023-08-14

Status : Active

Type : II

blank

05

IFT FIRST
Not Confirmed

05

IFT FIRST
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-21

Pay. Date : 2023-09-27

DMF Number : 38834

Submission : 2023-09-29

Status : Active

Type : II

blank

06

IFT FIRST
Not Confirmed

06

IFT FIRST
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2023-11-13

Pay. Date : 2023-08-14

DMF Number : 38715

Submission : 2023-09-28

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate IH

Date of Issue : 2022-09-16

Valid Till : 2025-09-15

Written Confirmation Number : WC-0536

Address of the Firm : #49, F1 & F2, Canara Bank Road, Bommasandra Industrial area, Phase 1, Bommasandr...

blank

02

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate IH

Date of Issue : 2022-06-06

Valid Till : 2025-06-05

Written Confirmation Number : WC-0523

Address of the Firm : Unit-II, No. 276-P & 277-P, Sy no.20, Bannikuppe Road, Harohalli Industrial area...

blank

03

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulphate (BHV-3000)/FCI 3582 IH

Date of Issue : 2022-06-29

Valid Till : 2025-02-07

Written Confirmation Number : WC-0123

Address of the Firm : Sy. Nos. 7-70, 70/1 & 70/2, Digwal Village, Kohir Mandai, Sangareddy District, T...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Limezepant sulfate hydrate

Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.

Registration Date : 2025-03-24

Registration Number : Number 87-41-ND

Manufacturer Name : Anthem Biosciences Private L...

Manufacturer Address : No. 49, F1 & F2 Canara Bank Road, BommasandraIndustrial Area, Phase I, Bommasandra, B...

blank

02

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

Limezepant sulfate hydrate

Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.

Registration Date : 2025-03-24

Registration Number : Number 87-42-ND

Manufacturer Name : Anthem Biosciences Private L...

Manufacturer Address : No.276-P & 277-P, SY No. 20, Bannikuppe Road, Harohalli Industrial Area, Phase II, Ka...

blank

03

Escientia

U.S.A
IFT FIRST
Not Confirmed
arrow

Escientia

U.S.A
arrow
IFT FIRST
Not Confirmed

Limezepant sulfate hydrate

Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.

Registration Date : 2025-03-24

Registration Number : Number 87-43-ND

Manufacturer Name : Escientia Advanced Sciences ...

Manufacturer Address : Plot No.11, 11A, 12 and 12A, APSEZ, Atchutapuram, Anakapalli District - 531011, Andhr...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

RIMEGEPANT SULFATE

NDC Package Code : 81912-0002

Start Marketing Date : 2023-09-22

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Moehs Iberica

02

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

NDC Package Code : 59651-884

Start Marketing Date : 2024-01-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

03

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT

NDC Package Code : 69989-0013

Start Marketing Date : 2020-10-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

04

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT

NDC Package Code : 69989-0009

Start Marketing Date : 2019-09-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

05

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT

NDC Package Code : 69989-0010

Start Marketing Date : 2019-09-24

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

06

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT

NDC Package Code : 69989-0012

Start Marketing Date : 2021-08-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

07

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT

NDC Package Code : 69989-0011

Start Marketing Date : 2021-04-19

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

08

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

NDC Package Code : 72804-0004

Start Marketing Date : 2023-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

09

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

NDC Package Code : 69766-112

Start Marketing Date : 2023-09-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

IFT FIRST
Not Confirmed
arrow
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

NDC Package Code : 65085-0081

Start Marketing Date : 2021-10-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678818600,"product":"RIMEGEPANT SULFATE - CONTROL BATCH NO 43","address":"12th floor,Commerz II, International Business Park, Oberoi","city":"Goregaon East","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"PLIVA HRVATSKA DOO FTOZ","customerCountry":"CROATIA","quantity":"9.35","actualQuantity":"9.35","unit":"KGS","unitRateFc":"37259","totalValueFC":"345931.6","currency":"USD","unitRateINR":3043101.604278075,"date":"15-Mar-2023","totalValueINR":"28453000","totalValueInUsd":"345931.6","indian_port":"DELHI AIR","hs_no":"29333100","bill_no":"8481517","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"12th floor,Commerz II, International Business Park, Oberoi, Goregaon East","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678818600,"product":"RIMEGEPANT SULFATE - CONTROL BATCH NO 43","address":"12th floor,Commerz II, International Business Park, Oberoi","city":"Goregaon East","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ZAGREB","customer":"PLIVA HRVATSKA DOO FTOZ","customerCountry":"CROATIA","quantity":"10.55","actualQuantity":"10.55","unit":"KGS","unitRateFc":"37259","totalValueFC":"390332.6","currency":"USD","unitRateINR":3043127.962085308,"date":"15-Mar-2023","totalValueINR":"32105000","totalValueInUsd":"390332.6","indian_port":"DELHI AIR","hs_no":"29333100","bill_no":"8481517","productDescription":"API","marketType":"REGULATED MARKET","country":"CROATIA","selfForZScoreResived":"Pharma Grade","supplierPort":"DELHI AIR","supplierAddress":"12th floor,Commerz II, International Business Park, Oberoi, Goregaon East","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1691173800,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"NA","city":"NA","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"NA","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"222.55","actualQuantity":"222.55","unit":"KGS","unitRateFc":"12910.7","totalValueFC":"2840795.1","currency":"USD","unitRateINR":1057384.8573354301,"date":"05-Aug-2023","totalValueINR":"235321000","totalValueInUsd":"2840795.1","indian_port":"HYDERABAD ICD","hs_no":"29333100","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"NA, NA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697049000,"product":"RIMEGEPANT SULFATE (RES)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"UNDISCLOSED","customerCountry":"UNITED ARAB EMIRATES","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"39600","totalValueFC":"39072.8","currency":"USD","unitRateINR":3252000,"date":"12-Oct-2023","totalValueINR":"3252000","totalValueInUsd":"39072.8","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"4575172","productDescription":"API","marketType":"","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703874600,"product":"WE INTEND TO CLAIM UNDER (RODTEP) SCHEME,FINE ORGANIC COMPOUND BATCH#A012340177,A012340178,A012340179 RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"89.70","actualQuantity":"89.7","unit":"KGS","unitRateFc":"13534.4","totalValueFC":"1206117.2","currency":"USD","unitRateINR":1119297.6588628762,"date":"30-Dec-2023","totalValueINR":"100401000","totalValueInUsd":"1206117.2","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6431181","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706380200,"product":"RIMEGEPANT SULFATE (RES)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"DUBAI","customer":"GULF AGENCY CO DUBAI LLC","customerCountry":"UNITED ARAB EMIRATES","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"44550","totalValueFC":"44081.5","currency":"USD","unitRateINR":3663685.5,"date":"28-Jan-2024","totalValueINR":"3663685.5","totalValueInUsd":"44081.5","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"7070698","productDescription":"API","marketType":"","country":"UNITED ARAB EMIRATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"RIMEGEPANT SULFATE INN (TAX INVOICE NO:6123010575 DT:12.02.2024)","address":"SYNO.257 258\/1, DNO.11-6\/56,","city":"VILLAGE BALANGAR POST HYDERABAD","supplier":"LEE PHARMA LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"PRIME BANK LTD","customerCountry":"BANGLADESH","quantity":"0.20","actualQuantity":"200","unit":"GMS","unitRateFc":"6","totalValueFC":"1135.1","currency":"USD","unitRateINR":470.89999999999998,"date":"21-Feb-2024","totalValueINR":"94180","totalValueInUsd":"1135.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"7710440","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"SYNO.257 258\/1, DNO.11-6\/56,, VILLAGE BALANGAR POST HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709317800,"product":"RIMEGEPANT SULFATE (RES)","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LIFE SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"MERKO PHARMACEUTICAL CHEMICAL","customerCountry":"TURKEY","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"30000","totalValueFC":"63145.6","currency":"EURO","unitRateINR":2621672.1699999999,"date":"02-Mar-2024","totalValueINR":"5243344.34","totalValueInUsd":"63145.6","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8001178","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709663400,"product":"RIMEGEPANT SULFATE","address":"FLAT NO.302, BHANU ENCLAVE","city":"HYDERABAD.AP","supplier":"METROCHEM API PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"RIO DE JANEIRO - GAL","customer":"ABBOTT LABORATORIES DO BRASIL","customerCountry":"BRAZIL","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"10500","totalValueFC":"31050.5","currency":"USD","unitRateINR":859433.33333333337,"date":"06-Mar-2024","totalValueINR":"2578300","totalValueInUsd":"31050.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8108775","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"FLAT NO.302, BHANU ENCLAVE, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711737000,"product":"FINE ORGANIC COMPOUND.-WE INTEND TO CLAIM UNDER RODTEP SCHEME .RIMEGEPANT SULFATE.BATCH# A012440060,A012440067,**","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON METROPOLITAN","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"299.30","actualQuantity":"299.3","unit":"KGS","unitRateFc":"13534.4","totalValueFC":"4012520.6","currency":"USD","unitRateINR":1113206.8676912796,"date":"30-Mar-2024","totalValueINR":"333182815.5","totalValueInUsd":"4012520.6","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"8784526","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714588200,"product":"RIMEGEPANT SULFATE PHARMACEUTICAL RAW MATERIALS","address":"FLAT NO.302, BHANU ENCLAVE","city":"HYDERABAD.AP","supplier":"METROCHEM API PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"RIO DE JANEIRO - GAL","customer":"ABBOTT LABORATORIES DO BRASIL LTDA","customerCountry":"BRAZIL","quantity":"5.62","actualQuantity":"5.62","unit":"KGS","unitRateFc":"10500","totalValueFC":"58052.2","currency":"USD","unitRateINR":861013.70106761565,"date":"02-May-2024","totalValueINR":"4838897","totalValueInUsd":"58052.2","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"9557437","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"FLAT NO.302, BHANU ENCLAVE, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723401000,"product":"(5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA(B)PYRIDIN-...(RIMEGEPANT SULFATE)","address":"101, SAPTAGIRI RESIDENCY,1-10-98\/A, CHIKOTI GARDENS, BEGUMPET,","city":"HYDERABAD, AP.","supplier":"ESCIENTIA ADVANCED SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON","customer":"CATALENT MICRON TECHNOLOGIES LTD","customerCountry":"UNITED KINGDOM","quantity":"66.00","actualQuantity":"66","unit":"KGS","unitRateFc":"12152","totalValueFC":"792197.2","currency":"USD","unitRateINR":1006793.1524242425,"date":"12-Aug-2024","totalValueINR":"66448348.06","totalValueInUsd":"792197.2","indian_port":"Vizag-APIICL SEZ","hs_no":"29333100","bill_no":"3137656","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-APIICL SEZ","supplierAddress":"101, SAPTAGIRI RESIDENCY,1-10-98\/A, CHIKOTI GARDENS, BEGUMPET,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1723401000,"product":"(5S,6S,9R)-5-AMINO-6-(2,3-DIFLUOROPHENYL-6,7,8,9-TETRAHYDRO-5H-CYCLOHEPTA(B)PYRIDIN-...(RIMEGEPANT SULFATE)","address":"101, SAPTAGIRI RESIDENCY,1-10-98\/A, CHIKOTI GARDENS, BEGUMPET,","city":"HYDERABAD, AP.","supplier":"ESCIENTIA ADVANCED SCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON","customer":"CATALENT MICRON TECHNOLOGIES LTD","customerCountry":"UNITED KINGDOM","quantity":"132.15","actualQuantity":"132.15","unit":"KGS","unitRateFc":"12152","totalValueFC":"1586194.9","currency":"USD","unitRateINR":1006793.2,"date":"12-Aug-2024","totalValueINR":"133047721.38","totalValueInUsd":"1586194.9","indian_port":"Vizag-APIICL SEZ","hs_no":"29333100","bill_no":"3137656","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-APIICL SEZ","supplierAddress":"101, SAPTAGIRI RESIDENCY,1-10-98\/A, CHIKOTI GARDENS, BEGUMPET,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725042600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMTHE BENEFIT UNDER RODTEP SCHEME (BATCHNO:A012440171) RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"28.70","actualQuantity":"28.7","unit":"KGS","unitRateFc":"12210","totalValueFC":"347174.4","currency":"USD","unitRateINR":1014651,"date":"31-Aug-2024","totalValueINR":"29120483.7","totalValueInUsd":"347174.4","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"3662019","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMUNDER RODTEP SCHEME(BATCHNO:A012440178,A012440180,A012440199)RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"71.60","actualQuantity":"71.6","unit":"KGS","unitRateFc":"13010","totalValueFC":"921498.2","currency":"USD","unitRateINR":1078529.0000000002,"date":"30-Sep-2024","totalValueINR":"77222676.4","totalValueInUsd":"921498.2","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"4485409","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727634600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMTHE BENEFIT UNDER RODTEP SCHEME (BATCHNO: A062440291) RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"80.00","actualQuantity":"80","unit":"KGS","unitRateFc":"12660","totalValueFC":"1001908","currency":"USD","unitRateINR":1049514,"date":"30-Sep-2024","totalValueINR":"83961120","totalValueInUsd":"1001908","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"4483001","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730226600,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATE(B\/NA012440226, A012440227,A012440228)","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"117.30","actualQuantity":"117.3","unit":"KGS","unitRateFc":"13010","totalValueFC":"1511061.3","currency":"USD","unitRateINR":1082432,"date":"30-Oct-2024","totalValueINR":"126969273.6","totalValueInUsd":"1511061.3","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"5299915","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730226600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDE(RODTEP)SCHEM(B\/N:A012440225,A012440226) RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"13010","totalValueFC":"515280.9","currency":"USD","unitRateINR":1082432,"date":"30-Oct-2024","totalValueINR":"43297280","totalValueInUsd":"515280.9","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"5299915","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1730226600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATEB\/N:A012440240,A012440242,A012440243","address":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"146.52","actualQuantity":"146.515","unit":"KGS","unitRateFc":"13010","totalValueFC":"1887409.5","currency":"USD","unitRateINR":1082431.9148210082,"date":"30-Oct-2024","totalValueINR":"158592512","totalValueInUsd":"1887409.5","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"5300641","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,BOMMASANDRA INDL.AREA,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"FINE ORGANIC COMPOUND - WE INTEND TO CLAIM THE BENEFIT UNDER RODTEP SCHEME (B\/N:A012440254,A012440255)RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"160.58","actualQuantity":"160.58","unit":"KGS","unitRateFc":"13010","totalValueFC":"2069633.2","currency":"USD","unitRateINR":1087636.0001245486,"date":"29-Nov-2024","totalValueINR":"174652588.9","totalValueInUsd":"2069633.2","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6042477","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMTHE BENEFIT UNDER RODTEP SCHEME (BATCHNO:A012440254,RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"177.83","actualQuantity":"177.83","unit":"KGS","unitRateFc":"13010","totalValueFC":"2291959.6","currency":"USD","unitRateINR":1087636.000112467,"date":"29-Nov-2024","totalValueINR":"193414309.9","totalValueInUsd":"2291959.6","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6042476","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMTHE UNDER RODTEP SCHEME (B\/N:A012440277,A012440275, RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"104.15","actualQuantity":"104.15","unit":"KGS","unitRateFc":"13010","totalValueFC":"1342335.9","currency":"USD","unitRateINR":1087636,"date":"29-Nov-2024","totalValueINR":"113277289.4","totalValueInUsd":"1342335.9","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6042475","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732818600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATEB\/N:A062440334,A062440357","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"168.00","actualQuantity":"168","unit":"KGS","unitRateFc":"12660","totalValueFC":"2107014.9","currency":"USD","unitRateINR":1058376,"date":"29-Nov-2024","totalValueINR":"177807168","totalValueInUsd":"2107014.9","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6040215","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"138.53","actualQuantity":"138.53","unit":"KGS","unitRateFc":"11930","totalValueFC":"1631870.9","currency":"USD","unitRateINR":1000926.9999278135,"date":"13-Dec-2024","totalValueINR":"138658417.3","totalValueInUsd":"1631870.9","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"6440101","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"152.29","actualQuantity":"152.29","unit":"KGS","unitRateFc":"11930","totalValueFC":"1793962.5","currency":"USD","unitRateINR":1000926.9998030076,"date":"13-Dec-2024","totalValueINR":"152431172.8","totalValueInUsd":"1793962.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"6440097","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"155.10","actualQuantity":"155.1","unit":"KGS","unitRateFc":"11930","totalValueFC":"1827064","currency":"USD","unitRateINR":1000927,"date":"13-Dec-2024","totalValueINR":"155243777.7","totalValueInUsd":"1827064","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"6440102","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"157.48","actualQuantity":"157.48","unit":"KGS","unitRateFc":"11930","totalValueFC":"1855100.2","currency":"USD","unitRateINR":1000927.0002540005,"date":"13-Dec-2024","totalValueINR":"157625984","totalValueInUsd":"1855100.2","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"6440100","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734028200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"159.76","actualQuantity":"159.76","unit":"KGS","unitRateFc":"11930","totalValueFC":"1881958.4","currency":"USD","unitRateINR":1000926.9998748123,"date":"13-Dec-2024","totalValueINR":"159908097.5","totalValueInUsd":"1881958.4","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"6440099","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735583400,"product":"FINE ORGANIC COMPOUND - WE INTEND TO CLAIM THE BENEFIT UNDER RODTEP SCHEME (B\/N:A012440280) RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"13010","totalValueFC":"193498.7","currency":"USD","unitRateINR":1096092.5,"date":"31-Dec-2024","totalValueINR":"16441387.5","totalValueInUsd":"193498.7","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6935717","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735583400,"product":"FINE ORGANIC COMPOUND - WE INTEND TO CLAIM UNDER RODTEP SCHEME RIMEGEPANT SULFATE(B\/N:A012440295,A012440296,A012440297)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"119.73","actualQuantity":"119.73","unit":"KGS","unitRateFc":"13010","totalValueFC":"1544506.5","currency":"USD","unitRateINR":1096092.4997911968,"date":"31-Dec-2024","totalValueINR":"131235155","totalValueInUsd":"1544506.5","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6936260","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735583400,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMTHE BENEFIT UNDER RODTEP SCHEME (B\/N:A012440281,A01244287 RIMEGEPANT SULFATE)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"178.20","actualQuantity":"178.2","unit":"KGS","unitRateFc":"13010","totalValueFC":"2298764.4","currency":"USD","unitRateINR":1096092.5,"date":"31-Dec-2024","totalValueINR":"195323683.5","totalValueInUsd":"2298764.4","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"6935953","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737052200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"145.76","actualQuantity":"145.76","unit":"KGS","unitRateFc":"11930","totalValueFC":"1722195","currency":"USD","unitRateINR":1018821.9998627881,"date":"17-Jan-2025","totalValueINR":"148503494.7","totalValueInUsd":"1722195","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"7355966","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737052200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"148.95","actualQuantity":"148.95","unit":"KGS","unitRateFc":"11930","totalValueFC":"1759885.8","currency":"USD","unitRateINR":1018822.0000000001,"date":"17-Jan-2025","totalValueINR":"151753536.9","totalValueInUsd":"1759885.8","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"7356054","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737052200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"150.51","actualQuantity":"150.51","unit":"KGS","unitRateFc":"11930","totalValueFC":"1778317.6","currency":"USD","unitRateINR":1018821.9998671184,"date":"17-Jan-2025","totalValueINR":"153342899.2","totalValueInUsd":"1778317.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"7355805","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737052200,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"155.09","actualQuantity":"155.09","unit":"KGS","unitRateFc":"11930","totalValueFC":"1832431.6","currency":"USD","unitRateINR":1018822.0001289573,"date":"17-Jan-2025","totalValueINR":"158009104","totalValueInUsd":"1832431.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"7356223","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"79.00","actualQuantity":"79","unit":"KGS","unitRateFc":"11930","totalValueFC":"939608","currency":"USD","unitRateINR":1034331,"date":"14-Feb-2025","totalValueINR":"81712149","totalValueInUsd":"939608","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8175159","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"155.00","actualQuantity":"155","unit":"KGS","unitRateFc":"11930","totalValueFC":"1846389.2","currency":"USD","unitRateINR":1035932.5419354839,"date":"14-Feb-2025","totalValueINR":"160569544","totalValueInUsd":"1846389.2","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8174936","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"157.00","actualQuantity":"157","unit":"KGS","unitRateFc":"11930","totalValueFC":"1872198.7","currency":"USD","unitRateINR":1037032.1210191083,"date":"14-Feb-2025","totalValueINR":"162814043","totalValueInUsd":"1872198.7","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8174900","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"159.00","actualQuantity":"159","unit":"KGS","unitRateFc":"11930","totalValueFC":"1892061.3","currency":"USD","unitRateINR":1034851.4150943396,"date":"14-Feb-2025","totalValueINR":"164541375","totalValueInUsd":"1892061.3","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8175011","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"159.00","actualQuantity":"159","unit":"KGS","unitRateFc":"11930","totalValueFC":"1892537","currency":"USD","unitRateINR":1035111.6289308176,"date":"14-Feb-2025","totalValueINR":"164582749","totalValueInUsd":"1892537","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8174973","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"11930","totalValueFC":"1903003.5","currency":"USD","unitRateINR":1034331,"date":"14-Feb-2025","totalValueINR":"165492960","totalValueInUsd":"1903003.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8174889","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1739471400,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)PACKED","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"HEATHROW APT\/LONDON, HIL","customer":"UNDISCLOSED","customerCountry":"UNITED KINGDOM","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"11930","totalValueFC":"1903003.5","currency":"USD","unitRateINR":1034331,"date":"14-Feb-2025","totalValueINR":"165492960","totalValueInUsd":"1903003.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8175047","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740076200,"product":"RIMEGEPANT SULFATE CONTROL BATCH NO 4321000423 MFG DT.DECEMBER 2022 RETEST DT. JUNE 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TEVA API INDIA PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"VTS TRANSPORT LOGISTICS","customerCountry":"NETHERLANDS","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"24799.7","totalValueFC":"6808.9","currency":"USD","unitRateINR":1973767.4333333333,"date":"21-Feb-2025","totalValueINR":"592130.23","totalValueInUsd":"6808.9","indian_port":"Delhi Air","hs_no":"29333100","bill_no":"8382035","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"79.20","actualQuantity":"79.2","unit":"KGS","unitRateFc":"11930","totalValueFC":"939210","currency":"USD","unitRateINR":1027172.9999999999,"date":"07-Mar-2025","totalValueINR":"81352101.6","totalValueInUsd":"939210","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818443","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"156.81","actualQuantity":"156.81","unit":"KGS","unitRateFc":"11930","totalValueFC":"1859564.7","currency":"USD","unitRateINR":1027172.9998086856,"date":"07-Mar-2025","totalValueINR":"161070998.1","totalValueInUsd":"1859564.7","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818643","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"157.75","actualQuantity":"157.75","unit":"KGS","unitRateFc":"11930","totalValueFC":"1870711.9","currency":"USD","unitRateINR":1027173.0003169572,"date":"07-Mar-2025","totalValueINR":"162036540.8","totalValueInUsd":"1870711.9","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818639","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"159.33","actualQuantity":"159.33","unit":"KGS","unitRateFc":"11930","totalValueFC":"1889448.6","currency":"USD","unitRateINR":1027173.0000627626,"date":"07-Mar-2025","totalValueINR":"163659474.1","totalValueInUsd":"1889448.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818447","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"11930","totalValueFC":"1897394","currency":"USD","unitRateINR":1027173,"date":"07-Mar-2025","totalValueINR":"164347680","totalValueInUsd":"1897394","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818438","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"RIMEGEPANT SULPHATE (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"11930","totalValueFC":"1897394","currency":"USD","unitRateINR":1027173,"date":"07-Mar-2025","totalValueINR":"164347680","totalValueInUsd":"1897394","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8818451","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742841000,"product":"FINE ORGANIC COMPOUND WE INTEND TO CLAIMUNDER REMISSION RODTEP SCHEME,RIMEGEPANT SULFATE","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"240.00","actualQuantity":"240","unit":"KGS","unitRateFc":"12660","totalValueFC":"3002704.9","currency":"USD","unitRateINR":1083696,"date":"25-Mar-2025","totalValueINR":"260087040","totalValueInUsd":"3002704.9","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"9348262","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1743273000,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"159.40","actualQuantity":"159.4","unit":"KGS","unitRateFc":"11930","totalValueFC":"1879301.5","currency":"USD","unitRateINR":1021207.9999999999,"date":"30-Mar-2025","totalValueINR":"162780555.2","totalValueInUsd":"1879301.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"9528732","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1743273000,"product":"RIMEGEPANT SULPHATE (FCI3582 (BHV-3000)","address":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK","city":"KURLA, MUMBAI","supplier":"PIRAMAL PHARMA LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"CATALENT MICRON TECHNOLOGIES","customerCountry":"UNITED KINGDOM","quantity":"160.00","actualQuantity":"160","unit":"KGS","unitRateFc":"11930","totalValueFC":"1886375.4","currency":"USD","unitRateINR":1021208,"date":"30-Mar-2025","totalValueINR":"163393280","totalValueInUsd":"1886375.4","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"9528730","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PIRAMAL ANANTA, PIRAMAL AGASTYA PARK, KURLA, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745173800,"product":"FINE ORGANIC COMPOUND - WE INTEND TO CLAIM UNDER RODTEP SCHEME RIMEGEPANT SULFATE(BATCH NO:A012540039)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"29.30","actualQuantity":"29.3","unit":"KGS","unitRateFc":"13010","totalValueFC":"377177.3","currency":"USD","unitRateINR":1101947,"date":"21-Apr-2025","totalValueINR":"32287047.1","totalValueInUsd":"377177.3","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"1142900","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745173800,"product":"FINE ORGANIC COMPOUND - WE INTEND TO CLAIM UNDER RODTEP SCHEME RIMEGEPANT SULFATE(BATCH NO:A012540073,A012540077)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"119.95","actualQuantity":"119.95","unit":"KGS","unitRateFc":"13010","totalValueFC":"1544110.2","currency":"USD","unitRateINR":1101947.3530637766,"date":"21-Apr-2025","totalValueINR":"132178585","totalValueInUsd":"1544110.2","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"1143030","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745173800,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATE(BATCH NO:A012540040,A012540055)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"177.25","actualQuantity":"177.25","unit":"KGS","unitRateFc":"13010","totalValueFC":"2281730","currency":"USD","unitRateINR":1101947.2389280677,"date":"21-Apr-2025","totalValueINR":"195320148.1","totalValueInUsd":"2281730","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"1142997","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745778600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATE(BATCH NO:A012540094,A012540096,)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"180.00","actualQuantity":"180","unit":"KGS","unitRateFc":"13010","totalValueFC":"2317130.1","currency":"USD","unitRateINR":1101947,"date":"28-Apr-2025","totalValueINR":"198350460","totalValueInUsd":"2317130.1","indian_port":"Bangalore Air","hs_no":"29333100","bill_no":"1350073","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745778600,"product":"FINE ORGANIC COMPOUND-WE INTEND TO CLAIMUNDER RODTEP SCHEME RIMEGEPANT SULFATE(BATCH NO:A062440412, A062440427)","address":"PLOT.NO.49,CANARA BANK ROAD,","city":"PHASE-I,BANGALORE","supplier":"ANTHEM BIOSCIENCES LTD","supplierCountry":"INDIA","foreign_port":"LONDON - HEATHROW","customer":"PROJECT MANAGER","customerCountry":"UNITED KINGDOM","quantity":"320.00","actualQuantity":"320","unit":"KGS","unitRateFc":"12660","totalValueFC":"4008522.2","currency":"USD","unitRateINR":1072302,"date":"28-Apr-2025","totalValueINR":"343136640","totalValueInUsd":"4008522.2","indian_port":"Bangalore Air","hs_no":"29339990","bill_no":"1349771","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED KINGDOM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"PLOT.NO.49,CANARA BANK ROAD,, PHASE-I,BANGALORE","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745778600,"product":"RIMEGEPANT SULFATE RIMEGEPANT SULFATE","address":"L\/204, MANTRI WOODLANDS, B.G. ROAD,","city":"KARNATAKA STATE","supplier":"NANTONG CHANYOO PHARMATECH CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TENSHI KAIZEN PRIVATE LTD","customerCountry":"INDIA","quantity":"0.70","actualQuantity":"0.7","unit":"KGS","unitRateFc":"27850","totalValueFC":"19676.8","currency":"USD","unitRateINR":"2406240","date":"28-Apr-2025","totalValueINR":"1684368","totalValueInUsd":"19676.8","indian_port":"Bangalore Air","hs_no":"29339990","bill_no":"9760007","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO 2 TONGHAI SI ROAD YANGKOU CHEMIC AL INDUSTRIAL PARK RUDONG COASTAL E COOMIC JIANGSU, China","customerAddress":"L\/204, MANTRI WOODLANDS, B.G. ROAD,"}]
15-Mar-2023
28-Apr-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Vydura (also known as Rimegepant) is an oral lyophilisate and is the first calcitonin gene-related peptide (CGRP) receptor antagonist migraine therapy to be accepted by the SMC.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Vydura

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Biohaven Pharmaceuticals

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 05, 2023

blank

01

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Details : Vydura (also known as Rimegepant) is an oral lyophilisate and is the first calcitonin gene-related peptide (CGRP) receptor antagonist migraine therapy to be accepted by the SMC.

Product Name : Vydura

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

October 05, 2023

blank

Details:

Pfizer will acquire Biohaven, the maker of NURTEC® ODT (rimegepant sulfate). Pfizer will commercialize NURTEC® ODT, an innovative compound for the prevention and acute treatment of migraine.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: $11,600.0 million Upfront Cash: $11,600.0 million

Deal Type: Acquisition October 05, 2022

blank

02

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Pfizer will acquire Biohaven, the maker of NURTEC® ODT (rimegepant sulfate). Pfizer will commercialize NURTEC® ODT, an innovative compound for the prevention and acute treatment of migraine.

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : $11,600.0 million

October 05, 2022

blank

Details:

Results from long-term studies of Nurtec ODT (Rimegepant Sulfate) as a preventive and acute treatment of migraine showed more than 80% of patients achieved ≥50% reduction in moderate or severe monthly migraine days and approximately half experienced a 100% reduction.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 06, 2022

blank

03

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Results from long-term studies of Nurtec ODT (Rimegepant Sulfate) as a preventive and acute treatment of migraine showed more than 80% of patients achieved ≥50% reduction in moderate or severe monthly migraine days and approximately half experienced a ...

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

September 06, 2022

blank

Details:

Results demonstrate a clinically meaningful reduction in opioid use of Nurtec® ODT (rimegepant) for patient population and may be of benefit to those reliant on opioids to manage their disease, thereby alleviating potential negative consequences of opioid use.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 04, 2022

blank

04

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Results demonstrate a clinically meaningful reduction in opioid use of Nurtec® ODT (rimegepant) for patient population and may be of benefit to those reliant on opioids to manage their disease, thereby alleviating potential negative consequences of opio...

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

July 04, 2022

blank

Details:

The transaction agreements, including Pfizer’s commercialization of rimegepant and zavegepant outside of the U.S., have become effective following the receipt of regulatory approvals and the satisfaction of other customary conditions and BHVN shares have been issued to Pfizer.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: $1,240.0 million Upfront Cash: $500.0 million

Deal Type: Collaboration May 01, 2022

blank

05

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : The transaction agreements, including Pfizer’s commercialization of rimegepant and zavegepant outside of the U.S., have become effective following the receipt of regulatory approvals and the satisfaction of other customary conditions and BHVN shares ha...

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : $500.0 million

May 01, 2022

blank

Details:

Results from the Phase 3 study published in Lancet demonstrated that a single dose of rimegepant provided superior pain reduction and associated symptoms of migraine at two hours compared to placebo.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 27, 2022

blank

06

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Results from the Phase 3 study published in Lancet demonstrated that a single dose of rimegepant provided superior pain reduction and associated symptoms of migraine at two hours compared to placebo.

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

April 27, 2022

blank

Details:

The acquisition brings to Pfizer a portfolio of promising calcitonin gene-related peptide (CGRP) receptor antagonists including NURTEC® ODT (rimegepant), to address needs of millions of migraine patients worldwide.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: $11,600.0 million Upfront Cash: $11,600.0 million

Deal Type: Acquisition March 10, 2022

blank

07

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : The acquisition brings to Pfizer a portfolio of promising calcitonin gene-related peptide (CGRP) receptor antagonists including NURTEC® ODT (rimegepant), to address needs of millions of migraine patients worldwide.

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : $11,600.0 million

March 10, 2022

blank

Details:

The CHMP of the EMA adopted a positive opinion for rimegepant, a CGRP receptor antagonist and, will now be reviewed by the European Commission, whose EU trade name will be VYDURA and it will be valid in all 27 EU member states for the treatment of migraine.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 25, 2022

blank

08

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : The CHMP of the EMA adopted a positive opinion for rimegepant, a CGRP receptor antagonist and, will now be reviewed by the European Commission, whose EU trade name will be VYDURA and it will be valid in all 27 EU member states for the treatment of migrai...

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 25, 2022

blank

Details:

Nurtec ODT, oral calcitonin-gene related peptide receptor antagonist currently approved for the acute and preventive treatment of migraine. Prior research has implicated CGRP in pathophysiology of disease and suggested therapeutic benefits of CGRP antagonism.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Brand Name: Nurtec ODT

Study Phase: Phase II/ Phase IIIProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 22, 2022

blank

09

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : Nurtec ODT, oral calcitonin-gene related peptide receptor antagonist currently approved for the acute and preventive treatment of migraine. Prior research has implicated CGRP in pathophysiology of disease and suggested therapeutic benefits of CGRP antago...

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 22, 2022

blank

Details:

NURTEC ODT (rimegepant) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a quick-dissolve ODT formulation that is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine.


Lead Product(s): Rimegepant Sulfate

Therapeutic Area: Neurology Brand Name: Nurtec ODT

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 14, 2022

blank

10

IFT FIRST
Not Confirmed
IFT FIRST
Not Confirmed

Details : NURTEC ODT (rimegepant) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a quick-dissolve ODT formulation that is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine.

Product Name : Nurtec ODT

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

February 14, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

CAS Number : 1190363-46-2

End Use API : Rimegepant Sulfate

About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...

Jinan Tantu Chemicals

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

CAS Number : 781649-84-1

End Use API : Rimegepant Sulfate

About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...

Jinan Tantu Chemicals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 781649-84-1

End Use API : Rimegepant Sulfate

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

CAS Number : 1190363-45-1

End Use API : Rimegepant Sulfate

About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...

Porton Company Banner

05

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 781649-84-1

End Use API : Rimegepant Sulfate

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

06

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 3612-20-2

End Use API : Rimegepant Sulfate

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

07

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 5382-16-1

End Use API : Rimegepant Sulfate

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

08

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 29976-53-2

End Use API : Rimegepant Sulfate

About The Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. i...

blank

09

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 39713-36-5

End Use API : Rimegepant Sulfate

About The Company : Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Inter...

blank

10

IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed
arrow

CAS Number : 39713-40-1

End Use API : Rimegepant Sulfate

About The Company : Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Inter...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Pfizer Inc

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

Brand Name : NURTEC ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 75MG BASE

Packaging :

Approval Date : 2020-02-27

Application Number : 212728

Regulatory Info : RX

Registration Country : USA

blank

02

Pfizer Inc

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Pfizer Inc

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Pfizer Inc

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

PFIZER

U.S.A
IFT FIRST
Not Confirmed
arrow

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

Brand Name : NURTEC ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL

Dosage Strength : EQ 75MG BASE

Approval Date : 2020-02-27

Application Number : 212728

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Pfizer AG

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer AG

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Pfizer AG

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer AG

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Pfizer AG

U.S.A
IFT FIRST
Not Confirmed
arrow

Pfizer AG

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepantum

Brand Name : Vydura ODT

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the US Food and Drug Administration (FDA) was reeling under the impact of the pandemic, new drug approvals by the agency dropped by 26 percent. But last year, FDA’s new drug approvals rebounded by an impressive 49 percent, with the Center for Drug Evaluation and Research (CDER) approving 55 new drugs in 2023. Of them, 36 percent were considered first-in-class, while small molecules made up for 62 percent of the total drugs approved (i.e. 34). FDA’s Center for Biologics Evaluation and Research (CBER) okayed 19 biologics in 2023 compared to eight in the previous year.The first half of 2023 saw the debut of vaccines for the all-too-common respiratory syncytial virus (RSV). Among the other notable approvals in H1 was Biogen and Eisai’s Alzheimer’s drug Leqembi (lecanemab). Out of the total 55 drug approvals, 29 came in H2 2023. This includes Vertex Pharmaceuticals and CRISPR Therapeutics’ Casgevy that relies on the Nobel Prize-winning CRISPR gene-editing technology. Casgevy has been approved as a treatment for sickle-cell disease (SCD) and β-thalassemia.While FDA witnessed a sharp rise in approvals in 2023, many other drug regulators didn’t. The European Medicines Agency (EMA) granted marketing authorization to 32 novel drugs in 2023, a fall from 33 in 2022. Similarly, Health Canada’s approvals in 2023 decreased to 38, compared to 45 in the previous year.As usual, oncology topped the list of drug approvals by therapeutic area, at 39 (as opposed to 35 in 2022). Rare diseases was the second most popular therapeutic area for drug approvals. With drugmakers clearly paying heed to the unmet needs of patients suffering from rare diseases, this therapeutic area sprinted from a 9 percent share and the fourth position among new approvals in 2022 to an impressive 34 percent share in 2023. A quarter of the new drug approvals were in infectious diseases, followed by immunology (19 percent) and neurology (7 percent).View New Drug Approvals in 2023 with Estimated Sales (Free Excel Available) Casgevy, postpartum depression drug Zurzuvae emerge as potential blockbustersGene therapy Casgevy, postpartum depression (PPD) med Zurzuvae, blood cancer med Elrexfio and ulcerative colitis drug Velsipity were some of the prominent approvals of 2023.Britain’s Medicines and Healthcare products Regulatory Agency was the first to okay Casgevy in November as a cure for SCD and β-thalassemia. Soon, the FDA approved it for SCD. In January this year, the American agency also approved it for transfusion-dependent β-thalassemia (TDT). Analysts estimate Casgevy to generate US$ 2.6 billion in peak sales, says Nature. Biogen and Sage’s PPD therapy Zurzuvae became the first and only FDA-approved pill for the condition that can be life-threatening for both the mother and the child. Global sales of Zurzuvae are forecast to hit US$ 1.28 billion by 2028.In August, Pfizer’s Elrexfio (elranatamab) became the first “off-the-shelf” (ready-to-use) therapy in the US for multiple myeloma. The drug provides an option for patients with hard to treat or relapsed blood cancer and is estimated to bring in US$ 861 million in peak sales by 2028, says Nature.Pfizer also bagged another significant approval in October — its drug Velsipity (etrasimod) was greenlit by the FDA to treat adults with ulcerative colitis, an inflammatory bowel disease. Peak revenue for Velsipity is expected to come in at US$ 825 million, as per Evaluate.View New Drug Approvals in 2023 with Estimated Sales (Free Excel Available) Astra’s Truqap, GSK’s Ojjaara among top cancer therapies given FDA nod in H2In November, FDA approved AstraZeneca’s Truqap (capivasertib) in combination with the Anglo-Swedish drugmaker’s Faslodex (fulvestrant) for treating adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations. Evaluate Pharma forecasts peak Truqap sales to come in at about US$ 690 million.In September, FDA approved GSK’s Ojjaara (momelotinib) as the first and only treatment for myelofibrosis with anemia. Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease. Ojjaara is taken orally once a day.Other notable oncology treatments okayed by FDA in H2 2023 include Daiichi’s Vanflyta (quizartinib) in July to treat an aggressive blood cancer known as acute myeloid leukemia (AML). In August, FDA approved Janssen’s bispecific antibody Talvey (talquetamab-tgvs) for difficult-to-treat blood cancer. The agency approved two cancer therapies in November — BMS’ Augtyro (repotrectinib) for ROS1-positive non-small cell lung cancer (NSCLC) and Takeda’s targeted oral therapy Fruzaqla (fruquintinib) for adult patients with metastatic colorectal cancer (mCRC).View New Drug Approvals in 2023 with Estimated Sales (Free Excel Available) Rare disease drugs Santhera-Catalyst’s Agamree, Novo’s Rivfloza bag approval in H2In October, FDA approved Santhera Pharmaceuticals and Catalyst Pharma’s Agamree (vamorolone), an oral suspension treatment for Duchenne muscular dystrophy (DMD) in patients two years of age and older. This makes it the first drug fully approved in both the US and Europe for the muscle degeneration disorder. Agamree acts in a manner similar to other steroids, which are the standard of care for the inherited rare disease. However, it causes fewer side effects.FDA also okayed Novo Nordisk’s once-a-month injection Rivfloza (nedosiran) in October to treat a rare genetic condition — primary hyperoxaluria type 1 (PH1) — that causes recurring kidney stones.In November, the agency approved Takeda’s Adzynma (ADAMTS13, recombinant-krhn) as the first treatment for both adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare genetic blood disorder. Other noteworthy FDA approvals in H2 2023 for rare blood diseases include Novartis’ Fabhalta and bluebird bio's Lyfgenia. Fabhalta is the first oral monotherapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria, a rare disease that causes symptoms such as hemolytic anemia, hemoglobinuria (excretion of hemoglobin in the urine), fatigue, shortness of breath etc. Lyfgenia is the first cell-based gene therapy for the treatment of SCD in patients 12 years and older. Similarly, another rare disease drug — Regeneron’s Veopoz —  bagged FDA approval in August last. Veopoz treats CHAPLE disease, an ultra-rare disease in which patients have severe gastrointestinal problems.View New Drug Approvals in 2023 with Estimated Sales (Free Excel Available) Our viewAfter a lull in 2022, new drug approvals have finally gathered momentum. The good news is that this year, several pathbreaking drugs are coming up for approval, such as Madrigal Pharmaceuticals’ resmetirom (the first treatment for NASH with liver fibrosis), Merck’s sotatercept (a treatment for pulmonary arterial hypertension), Lilly’s donanemab for Alzheimer’s disease and Karuna Therapeutics’ drug to treat schizophrenia. Let’s hope 2024 turns out to be an even bigger year for new drug approvals.

Impressions: 3920

https://www.pharmacompass.com/radio-compass-blog/fda-approvals-rise-49-in-2023-crispr-s-gene-editing-therapy-sees-light-of-day

#PharmaFlow by PHARMACOMPASS
01 Feb 2024

NEWS #PharmaBuzz

read-more
read-more
Pfizer to press pause on large M&A deals, CEO says
Pfizer to press pause on large M&A deals, CEO says

11 Jun 2024

// Fraiser Kansteiner FIERCE PHARMA

https://www.fiercepharma.com/pharma/pfizer-ceo-says-company-needs-take-breathing-period-after-massive-ma-stretch

Fraiser Kansteiner FIERCE PHARMA
11 Jun 2024

https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-rimegepant-sulfate-nurtec-odt-tablets-71965.pdf

FDA
26 Apr 2024
Lady Gaga returns in a new Nurtec migraine ad for Pfizer
Lady Gaga returns in a new Nurtec migraine ad for Pfizer

09 Apr 2024

// Beth Snyder Bulik ENDPTS

https://endpts.com/lady-gaga-returns-in-a-new-nurtec-migraine-ad-for-pfizer/

Beth Snyder Bulik ENDPTS
09 Apr 2024
Pfizer's Vydura gets NICE nod to treat episodic migraine attacks
Pfizer's Vydura gets NICE nod to treat episodic migraine attacks

13 Sep 2023

// Kevin Dunleavy FIERCE PHARMA

https://www.fiercepharma.com/pharma/late-party-nice-finally-signs-pfizers-nurtec-treat-migraine-attacks

Kevin Dunleavy FIERCE PHARMA
13 Sep 2023

https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-migraine-drug-fails-meet-main-goal-post-approval-study-2023-06-16/

REUTERS
17 Jun 2023

https://endpts.com/nice-recommends-pfizer-migraine-drug-in-uk-with-restrictions/

Paul Schloesser ENDPTS
01 Jun 2023

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed

Company : Biohaven Pharma

Rimegepant Sulfate

Drug Cost (USD) : 478,240,312

Year : 2023

Prescribers : 83811

Prescriptions : 329578

blank

02

arrow
IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed

Company : Biohaven Pharma

Rimegepant Sulfate

Drug Cost (USD) : 276,493,155

Year : 2022

Prescribers : 56513

Prescriptions : 207402

blank

03

arrow
IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed

Company : Biohaven Pharma

Rimegepant Sulfate

Drug Cost (USD) : 118,402,787

Year : 2021

Prescribers : 32315

Prescriptions : 104314

blank

04

arrow
IFT FIRST
Not Confirmed
arrow
IFT FIRST
Not Confirmed

Company : Biohaven Pharma

Rimegepant Sulfate

Drug Cost (USD) : 18,933,232

Year : 2020

Prescribers : 8957

Prescriptions : 19444

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Price Per Pack (Euro) : 50.61

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

02

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Price Per Pack (Euro) : 202.53

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

03

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Brand Name : Vydura ODT

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate

Dosage Form : Schmelztabl

Dosage Strength : 75mg

Price Per Pack (Euro) : 404.89

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

read-more
read-more

01

Brand Name : Nurtec ODT/Vydura

Rimegepant

arrow
IFT FIRST
Not Confirmed

Brand Name : Nurtec ODT/Vydura

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 213

2021 Revenue in Millions : 0

Growth (%) : 100

blank

02

Brand Name : Nurtec ODT/Vydura

Rimegepant

arrow
IFT FIRST
Not Confirmed

Brand Name : Nurtec ODT/Vydura

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 928

2022 Revenue in Millions : 213

Growth (%) : 336

blank

03

Brand Name : Nurtec ODT/Vydura

Rimegepant Sulfate

arrow
IFT FIRST
Not Confirmed

Brand Name : Nurtec ODT/Vydura

U.S.A
arrow
IFT FIRST
Not Confirmed

Rimegepant Sulfate

Main Therapeutic Indication : Neurology

Currency : USD

2024 Revenue in Millions : 1,263

2023 Revenue in Millions : 928

Growth (%) : 36

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

US Patent Number : 8759372

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212728

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-02-25

blank

02

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

US Patent Number : 8314117

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212728

Patent Use Code : U-3142

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-09

blank

03

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

US Patent Number : 8314117

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212728

Patent Use Code : U-2718

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-03-09

blank

04

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

US Patent Number : 11083724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212728

Patent Use Code : U-3142

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-25

blank

05

arrow
IFT FIRST
Not Confirmed

PFIZER

U.S.A
arrow
IFT FIRST
Not Confirmed

RIMEGEPANT SULFATE

US Patent Number : 11083724

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212728

Patent Use Code : U-2718

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-03-25

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 1374024-48-2 / Rimegepant Sulfate API manufacturers, exporters & distributors?

Rimegepant Sulfate manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Rimegepant Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rimegepant Sulfate manufacturer or Rimegepant Sulfate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rimegepant Sulfate manufacturer or Rimegepant Sulfate supplier.

PharmaCompass also assists you with knowing the Rimegepant Sulfate API Price utilized in the formulation of products. Rimegepant Sulfate API Price is not always fixed or binding as the Rimegepant Sulfate Price is obtained through a variety of data sources. The Rimegepant Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Rimegepant Sulfate

Synonyms

Nurtec odt, Rimegepant sulfate [usan], 1374024-48-2, 1383nm3q0h, Rimegepant sulfate (usan), 1-piperidinecarboxylic acid, 4-(2,3-dihydro-2-oxo-1h-imidazo(4,5-b)pyridin-1-yl)-, (5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl ester, sulfate, hydrate (2:1:3)

Cas Number

1374024-48-2

Unique Ingredient Identifier (UNII)

1383NM3Q0H

Nurtec odt (TN) Manufacturers

A Nurtec odt (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nurtec odt (TN), including repackagers and relabelers. The FDA regulates Nurtec odt (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nurtec odt (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Nurtec odt (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Nurtec odt (TN) Suppliers

A Nurtec odt (TN) supplier is an individual or a company that provides Nurtec odt (TN) active pharmaceutical ingredient (API) or Nurtec odt (TN) finished formulations upon request. The Nurtec odt (TN) suppliers may include Nurtec odt (TN) API manufacturers, exporters, distributors and traders.

click here to find a list of Nurtec odt (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Nurtec odt (TN) USDMF

A Nurtec odt (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Nurtec odt (TN) active pharmaceutical ingredient (API) in detail. Different forms of Nurtec odt (TN) DMFs exist exist since differing nations have different regulations, such as Nurtec odt (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Nurtec odt (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Nurtec odt (TN) USDMF includes data on Nurtec odt (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nurtec odt (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Nurtec odt (TN) suppliers with USDMF on PharmaCompass.

Nurtec odt (TN) KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Nurtec odt (TN) Drug Master File in Korea (Nurtec odt (TN) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nurtec odt (TN). The MFDS reviews the Nurtec odt (TN) KDMF as part of the drug registration process and uses the information provided in the Nurtec odt (TN) KDMF to evaluate the safety and efficacy of the drug.

After submitting a Nurtec odt (TN) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nurtec odt (TN) API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Nurtec odt (TN) suppliers with KDMF on PharmaCompass.

Nurtec odt (TN) WC

A Nurtec odt (TN) written confirmation (Nurtec odt (TN) WC) is an official document issued by a regulatory agency to a Nurtec odt (TN) manufacturer, verifying that the manufacturing facility of a Nurtec odt (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nurtec odt (TN) APIs or Nurtec odt (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Nurtec odt (TN) WC (written confirmation) as part of the regulatory process.

click here to find a list of Nurtec odt (TN) suppliers with Written Confirmation (WC) on PharmaCompass.

Nurtec odt (TN) NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nurtec odt (TN) as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Nurtec odt (TN) API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Nurtec odt (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Nurtec odt (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nurtec odt (TN) NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Nurtec odt (TN) suppliers with NDC on PharmaCompass.

Nurtec odt (TN) GMP

Nurtec odt (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Nurtec odt (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nurtec odt (TN) GMP manufacturer or Nurtec odt (TN) GMP API supplier for your needs.

Nurtec odt (TN) CoA

A Nurtec odt (TN) CoA (Certificate of Analysis) is a formal document that attests to Nurtec odt (TN)'s compliance with Nurtec odt (TN) specifications and serves as a tool for batch-level quality control.

Nurtec odt (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Nurtec odt (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Nurtec odt (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Nurtec odt (TN) EP), Nurtec odt (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nurtec odt (TN) USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty